Table 2.
Model Type | CoQ10 Formulation | Total Dosage | Treatment Effects |
Refs. | |
---|---|---|---|---|---|
On CoQ10 Levels | On ETC Function | ||||
Oral feeding | |||||
Wild-type mice | |||||
CoQ10 in chow | 0.5% CoQ10, 3 mo | Kidney ↑, liver ↑↑, brain ↔ | ND | (90) | |
CoQ10 in chow | 93 or 371 mg/kg body wt/day, 3.5 or 17.5 mo | Heart ↑, liver ↑↑, kidney ↑↑, skeletal muscle ↑↑, brain ↔, mito (liver, heart, kidney, skeletal muscle) ↑ | Respiration of liver mito. ↔ | (367) | |
Liposomal CoQ10 in drinking water | ∼300–400 mg/kg body wt/day, 3–7 mo | Liver ↑↑↑, muscle ↔, heart ↔, kidney ↔ | NE | (82, 123) | |
CoQ10 in chow | 2.81 mg/g CoQ10 in food, 3 wk | Liver and liver mito. ↑↑↑ | NE | (8) | |
Liposomal CoQ10 in drinking water | 0.4 mg/mL, 12–13 wk | Liver ↑↑↑; ovaries ↑↑, kidney ↔ | oocyte mito. respiration and ATP ↑ | (325) | |
Liquid CoQ10 | 15 mg/kg/day for 3 mo | Liver ↑↑; muscle ↔, | ND | (117) | |
CoQ deficiency mouse models | |||||
Pdss2kd/kd | CoQ10 in chow | 0.5% CoQ10 in food, 3 mo | Kidney ↑, liver ↑↑, brain ↔ | Kidney CI-III and CI-III ↔ | (90) |
Pdss2kd/kd | Liposomal CoQ10 in drinking water | ∼200 mg/kg body wt/day, 3.5 mo | Kidney ↔ | ND | (347) |
Coq7 KO | Liposomal CoQ10 in drinking water | ∼300–400 mg/kg body wt/day, 3–7 mo | Liver ↑↑↑, muscle ↔, heart ↔, kidney ↔ | Respiration of liver mito. ↑ | (82, 123) |
Coq7+/ | CoQ10 in chow | 2.81 mg/g CoQ10 in food, 3 wk | Liver and mito ↑↑↑ | Liver CI-CIII ↑ | (8) |
Coq9R239X | Liquid CoQ10 | 240 mg/kg body wt/day, 2 mo | Liver ↑↑, muscle ↑↑, heart ↔, kidney ↔, brain ↔, kidney ↔ | Cerebrum mito. CI-CIII ↔, CII-CIII ↔ | (368) |
Coq9R239X | Liquid CoQ10H2 | 240 mg/kg body wt/day, 2 mo | Liver ↑↑, kidney ↑, muscle ↑↑, heart ↑, kidney ↑, brain ↑, cerebrum mito. ↑ | Cerebrum mito. CI-CIII ↑ CII-CIII ↑ | (89, 368) |
ADCK2+/− | Liquid CoQ10 | 15 mg/kg/day for 3 mo | Liver ↑↑; muscle ↑ | ND | (117) |
Intraperitoneal injection | |||||
Wild-type mice | Intralipid-solubilized CoQ10 | 200 µL of 1.45 mM once | Liver ↑↑↑, BAT ↑↑, skeletal muscle ↔, serum ↔ | NE | (356) |
CoQ10 in 10% Tween 20 | 0.1 mg/g/day for 3 days | Heart mito. ↔ | NE | (369) | |
Intravenous administration | |||||
Wild-type mice | Micellar CoQ10 solution prepared with caspofungin | 12.0 mg/kg body wt/day, 10 days | Plasma ↑↑↑, liver↑↑↑, heart ↑↑, muscle ↑↑, kidney↑, spleen↑↑, lung ↑↑, brain ↑, heart mito ↑ | ND | (42) |
BAT, brown adipose tissue; CI-CIII, complex I-III activity; CII-CIII, complex II-III activity; ETC, electron transport chain; mito., mitochondria; ND, not determined; NE, no effect. ↑<2-fold increase of CoQ10 levels; ↑↑2- to 10-fold increase of CoQ10 levels; ↑↑↑≥10-fold increase of CoQ10 levels; ↔no change in CoQ10 levels.